| Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia (NCT05429905) | KK Women's and Children's Hospital | 2022-07-18 |
| CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol (NCT05648019) | KK Women's and Children's Hospital | 2022-03-15 |
| CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia (NCT05043571) | National University Hospital, Singapore | 2021-09-08 |
| ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia. (NCT05038696) | National University Hospital, Singapore | 2021-04-28 |
| Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO) (NCT04747912) | University of Chicago | 2021-03-02 |
| An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) (NCT04145531) | Jazz Pharmaceuticals | 2019-12-27 |
| Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma (NCT03328104) | Emory University | 2018-07-24 |
| Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL (NCT03564704) | Nanfang Hospital, Southern Medical University | 2016-02-14 |
| Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia (NCT01615809) | Fundació Sant Joan de Déu | 2011-10-01 |
| Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors (NCT01100658) | University of Minnesota | 2010-05-01 |
| Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies (NCT00988013) | University of Illinois at Chicago | 2009-09-01 |
| Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor (NCT00967343) | Kiadis Pharma | 2009-08-01 |
| Rapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid Malignancies (NCT00776373) | Abramson Cancer Center at Penn Medicine | 2007-01-01 |
| Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma (NCT00866749) | M.D. Anderson Cancer Center | 2006-09-12 |
| Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma (NCT00388531) | PETHEMA Foundation | 2006-03-01 |
| Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus (NCT00133367) | Massachusetts General Hospital | 2005-08-01 |
| Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant (NCT00354120) | Gruppo Italiano Trapianto di Midollo Osseo | 2005-03-01 |